Fractions of specific isoforms of 4-hydroxy-2-nonenal-modified DJ-1 differed significantly in patients with PD and controls (Lin et al. 2012) and within stages of PD, suggesting a potential as a staging biological marker of disease. The gene discussed is PARK7; the disease is Parkinson disease.